BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Díaz-Jiménez D, Núñez LE, Beltrán CJ, Candia E, Suazo C, Álvarez-Lobos M, González MJ, Hermoso MA, Quera R. Soluble ST2: A new and promising activity marker in ulcerative colitis. World J Gastroenterol 2011; 17(17): 2181-2190 [PMID: 21633527 DOI: 10.3748/wjg.v17.i17.2181]
URL: https://www.wjgnet.com/1007-9327/full/v17/i17/2181.htm
Number Citing Articles
1
Luca Pastorelli, Carlo De Salvo, Maurizio Vecchi, Theresa T. Pizarro. The Role of IL-33 in Gut Mucosal InflammationMediators of Inflammation 2013; 2013: 1 doi: 10.1155/2013/608187
2
Meng Wang, Guannan Shen, Liangguo Xu, Xiaodong Liu, Jared M. Brown, Dechun Feng, Ruth Ann Ross, Bin Gao, Suthat Liangpunsakul, Cynthia Ju. IL-1 receptor like 1 protects against alcoholic liver injury by limiting NF-κB activation in hepatic macrophagesJournal of Hepatology 2018; 68(1): 109 doi: 10.1016/j.jhep.2017.08.023
3
Cheng Pei, Mark Barbour, Karen J. Fairlie‐Clarke, Debbie Allan, Rong Mu, Hui‐Rong Jiang. Emerging role of interleukin‐33 in autoimmune diseasesImmunology 2014; 141(1): 9 doi: 10.1111/imm.12174
4
Abdulraouf M. Ramadan, Etienne Daguindau, Jason C. Rech, Krishnapriya Chinnaswamy, Jilu Zhang, Greg L. Hura, Brad Griesenauer, Zachary Bolten, Aaron Robida, Martha Larsen, Jeanne A. Stuckey, Chao-Yie Yang, Sophie Paczesny. From proteomics to discovery of first-in-class ST2 inhibitors active in vivoJCI Insight 2018; 3(14) doi: 10.1172/jci.insight.99208
5
Qing Zhao, Guangjie Chen. Role of IL-33 and Its Receptor in T Cell-Mediated Autoimmune DiseasesBioMed Research International 2014; 2014: 1 doi: 10.1155/2014/587376
6
Yi Fengming, Wu Jianbing. Biomarkers of Inflammatory Bowel DiseaseDisease Markers 2014; 2014: 1 doi: 10.1155/2014/710915
7
Yi Wang, Chengwei He, Shuzi Xin, Xiaohui Liu, Sitian Zhang, Boya Qiao, Hongwei Shang, Lei Gao, Jingdong Xu. A Deep View of the Biological Property of Interleukin-33 and Its Dysfunction in the GutInternational Journal of Molecular Sciences 2023; 24(17): 13504 doi: 10.3390/ijms241713504
8
Benjamin Dieplinger, Thomas Mueller. Soluble ST2 in heart failureClinica Chimica Acta 2015; 443: 57 doi: 10.1016/j.cca.2014.09.021
9
Linqing Xie, Guichan Liao, Hongjie Chen, Muye Xia, Xuan Huang, Rong Fan, Jie Peng, Xiaoyong Zhang, Hongyan Liu. Elevated expression of serum soluble ST2 in clinical relapse after stopping long-term Nucleos(t)ide analogue therapy for chronic hepatitis BBMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4261-3
10
Maciej Idzik, Jakub Poloczek, Bronisława Skrzep-Poloczek, Elżbieta Chełmecka, Jerzy Jochem, Dominika Stygar, Jolanta Czuczejko. General Rehabilitation Program after Knee or Hip Replacement Significantly Influences Erythrocytes Oxidative Stress Markers and Serum ST2 LevelsOxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/1358858
11
Jiarui Mi, Xia Wu, Xiaoyin Bai, Yang Yang, Hong Yang. ST2 and CSF‐1 as potential druggable targets of inflammatory bowel diseases: Results from two‐sample Mendelian randomization studyClinical and Translational Science 2023; 16(2): 236 doi: 10.1111/cts.13442
12
Changchang Ge, Yi Lu, Hong Shen, Lei Zhu. Monitoring of intestinal inflammation and prediction of recurrence in ulcerative colitisScandinavian Journal of Gastroenterology 2022; 57(5): 513 doi: 10.1080/00365521.2021.2022193
13
Jingyun Xu, Lijia Wu, Pengcheng Yu, Yichun Sun, Yixin Lu. Effect of T. spiralis Serine protease inhibitors on TNBS-induced experimental colitis mediated by MacrophagesScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-60155-7
14
Jiayun Shen, Qing Shang, Chun-Kwok Wong, Edmund K. Li, Shang Wang, Rui-Jie Li, Ka-Lai Lee, Ying-Ying Leung, King-Yee Ying, Cheuk-Wan Yim, Emily W. Kun, Moon-Ho Leung, Martin Li, Tena K. Li, Tracy Y. Zhu, Shui-Lian Yu, Woon-Pang Kuan, Cheuk-Man Yu, Lai-Shan Tam. IL-33 and soluble ST2 levels as novel predictors for remission and progression of carotid plaque in early rheumatoid arthritis: A prospective studySeminars in Arthritis and Rheumatism 2015; 45(1): 18 doi: 10.1016/j.semarthrit.2015.02.001
15
C.P. Peters, J.M. Mjösberg, J.H. Bernink, H. Spits. Innate lymphoid cells in inflammatory bowel diseasesImmunology Letters 2016; 172: 124 doi: 10.1016/j.imlet.2015.10.004
16
Abdulraouf M. Ramadan, Etienne Daguindau, Jason C. Rech, Krishnapriya Chinnaswamy, Jilu Zhang, Brad Griesenauer, Zachary Bolten, Aaron Robida, Martha Larsen, Jeanne A. Stuckey, Chao-Yie Yang, Sophie Paczesny. Inhibition of Biomarker ST2 by Small Molecules Improves Survival in Allogeneic Hematopoietic Cell TransplantationSSRN Electronic Journal 2018;  doi: 10.2139/ssrn.3155805
17
Fernando Magro, Susana Lopes, Marco Silva, Rosa Coelho, Francisco Portela, Diogo Branquinho, Luís Correia, Samuel Fernandes, Marília Cravo, Paulo Caldeira, Helena Tavares de Sousa, Marta Patita, Paula Lago, Jaime Ramos, Joana Afonso, Isabel Redondo, Patrícia Machado, George Philip, Joanne Lopes, Fátima Carneiro. Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumabTherapeutic Advances in Gastroenterology 2019; 12 doi: 10.1177/1756284819869141
18
Geethani Bandara, Michael A. Beaven, Ana Olivera, Alasdair M. Gilfillan, Dean D. Metcalfe. Activated mast cells synthesize and release soluble ST2‐a decoy receptor for IL‐33European Journal of Immunology 2015; 45(11): 3034 doi: 10.1002/eji.201545501
19
Chao-Yie Yang. Comparative Analyses of the Conformational Dynamics Between the Soluble and Membrane-Bound Cytokine ReceptorsScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-64034-z
20
Mohammad-Ali Jenabian, Mohamed El-Far, Kishanda Vyboh, Ido Kema, Cecilia T. Costiniuk, Rejean Thomas, Jean-Guy Baril, Roger LeBlanc, Cynthia Kanagaratham, Danuta Radzioch, Ossama Allam, Ali Ahmad, Bertrand Lebouché, Cécile Tremblay, Petronela Ancuta, Jean-Pierre Routy. Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV InfectionJournal of Infectious Diseases 2015; 212(3): 355 doi: 10.1093/infdis/jiv037
21
P. Kourkoulis, C. Kapizioni, G. Michalopoulos, N.P. Andreou, I. Papaconstantinou, G. Karamanolis, M. Gazouli. Novel potential biomarkers for the diagnosis and monitoring of patients with ulcerative colitisEuropean Journal of Gastroenterology & Hepatology 2019; 31(10): 1173 doi: 10.1097/MEG.0000000000001490
22
Thomas Mueller, Allan S. Jaffe. Soluble ST2—Analytical ConsiderationsThe American Journal of Cardiology 2015; 115(7): 8B doi: 10.1016/j.amjcard.2015.01.035
23
Brad Griesenauer, Sophie Paczesny. The ST2/IL-33 Axis in Immune Cells during Inflammatory DiseasesFrontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00475
24
Renata D’Incà, Giulia Sturniolo. Biomarkers in IBD: What to Utilize for the Diagnosis?Diagnostics 2023; 13(18): 2931 doi: 10.3390/diagnostics13182931
25
Kaden L. Nystuen, Shannon M. McNamee, Monica Akula, Kristina M. Holton, Margaret M. DeAngelis, Neena B. Haider. Alzheimer’s Disease: Models and Molecular Mechanisms Informing Disease and TreatmentsBioengineering 2024; 11(1): 45 doi: 10.3390/bioengineering11010045
26
Gökcan Öztürk, Deniz Bayrakoğlu, Şule Haskoloğlu, Kübra Baskın, Nazlı Deveci, Elif İnce, Talia İleri, Hasan Çakmaklı, Mehmet Ertem, Aydan İkincioğulları, Figen Doğu. ST2 and Reg3α: Can they predict aGvHD, steroid refractoriness and transplant-related mortality in pediatric patients after HSCT?Hematology, Transfusion and Cell Therapy 2024; 46: S129 doi: 10.1016/j.htct.2024.02.026
27
Jilu Zhang, Abdulraouf M. Ramadan, Brad Griesenauer, Wei Li, Matthew J. Turner, Chen Liu, Reuben Kapur, Helmut Hanenberg, Bruce R. Blazar, Isao Tawara, Sophie Paczesny. ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host diseaseScience Translational Medicine 2015; 7(308) doi: 10.1126/scitranslmed.aab0166
28
Weiwei Jiang, Xuhang Li. Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted TherapyMolecular Diagnosis & Therapy 2015; 19(3): 141 doi: 10.1007/s40291-015-0142-7
29
Małgorzata Krzystek-Korpacka, Radosław Kempiński, Mariusz Bromke, Katarzyna Neubauer. Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in AdultsDiagnostics 2020; 10(6): 367 doi: 10.3390/diagnostics10060367
30
Salih Boga, Huseyin Alkim, Ali Riza Koksal, Ayse Aysim Ozagari, Mehmet Bayram, Sebnem Tekin Neijmann, Ilker Sen, Canan Alkim. Serum St2 in Inflammatory Bowel Disease: A Potential Biomarker for Disease ActivityJournal of Investigative Medicine 2016; 64(5): 1016 doi: 10.1136/jim-2016-000062
31
Thomas Mueller, Benjamin Dieplinger. The Presage®ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2Expert Review of Molecular Diagnostics 2013; 13(1): 13 doi: 10.1586/erm.12.128
32
Florent Artru, Mohamed Bou Saleh, François Maggiotto, Guillaume Lassailly, Massih Ningarhari, Julie Demaret, Line-Carolle Ntandja-Wandji, Jean-Paul Pais de Barros, Julien Labreuche, Elodie Drumez, Doumet Georges Helou, Sébastien Dharancy, Emilie Gantier, Axel Périanin, Sylvie Chollet-Martin, Ramon Bataller, Philippe Mathurin, Laurent Dubuquoy, Alexandre Louvet. IL-33/ST2 pathway regulates neutrophil migration and predicts outcome in patients with severe alcoholic hepatitisJournal of Hepatology 2020; 72(6): 1052 doi: 10.1016/j.jhep.2019.12.017
33
David Díaz-Jiménez, Lucía Núñez, Marjorie De la Fuente, Karen Dubois-Camacho, Hugo Sepúlveda, Martín Montecino, Alejandro Torres-Riquelme, Paulina García-González, Jonás Chnaiderman, Anna Vossenkamper, Thomas T. MacDonald, Daniela Simian, María-Julieta González, John A. Cidlowski, Rodrigo Quera, Marcela A. Hermoso. A functional IL1RL1 variant regulates corticosteroid-induced sST2 expression in ulcerative colitisScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-10465-0
34
Aurora Holgado, Harald Braun, Elien Van Nuffel, Sammy Detry, Martijn J. Schuijs, Kim Deswarte, Karl Vergote, Mira Haegman, Griet Baudelet, Jurgen Haustraete, Hamida Hammad, Bart N. Lambrecht, Savvas N. Savvides, Inna S. Afonina, Rudi Beyaert. IL-33trap is a novel IL-33–neutralizing biologic that inhibits allergic airway inflammationJournal of Allergy and Clinical Immunology 2019; 144(1): 204 doi: 10.1016/j.jaci.2019.02.028
35
Aysan Moeinafshar, Niloufar Yazdanpanah, Nima Rezaei. Diagnostic biomarkers of dilated cardiomyopathyImmunobiology 2021; 226(6): 152153 doi: 10.1016/j.imbio.2021.152153
36
Chris Schiering, Thomas Krausgruber, Agnieszka Chomka, Anja Fröhlich, Krista Adelmann, Elizabeth A. Wohlfert, Johanna Pott, Thibault Griseri, Julia Bollrath, Ahmed N. Hegazy, Oliver J. Harrison, Benjamin M. J. Owens, Max Löhning, Yasmine Belkaid, Padraic G. Fallon, Fiona Powrie. The alarmin IL-33 promotes regulatory T-cell function in the intestineNature 2014; 513(7519): 564 doi: 10.1038/nature13577
37
Ying Xiao, Don W. Powell, Xiaowei Liu, Qingjie Li. Cardiovascular manifestations of inflammatory bowel diseases and the underlying pathogenic mechanismsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2023; 325(2): R193 doi: 10.1152/ajpregu.00300.2022
38
Cristina Sastre, Matthew B. Bevers, W. Taylor Kimberly. Role of Interleukin-1 Receptor-Like 1 (ST2) in Cerebrovascular DiseaseNeurocritical Care 2021; 35(3): 887 doi: 10.1007/s12028-021-01284-3
39
Hiroshi Takeyama, Tsunekazu Mizushima, Hideki Iijima, Shinzaki Shinichiro, Mamoru Uemura, Junichi Nishimura, Taishi Hata, Ichiro Takemasa, Hirofumi Yamamoto, Yuichiro Doki, Masaki Mori. Platelet Activation Markers Are Associated with Crohn’s Disease Activity in Patients with Low C-Reactive ProteinDigestive Diseases and Sciences 2015; 60(11): 3418 doi: 10.1007/s10620-015-3745-2
40
David Díaz-Jiménez, Marjorie De la Fuente, Karen Dubois-Camacho, Glauben Landskron, Janitza Fuentes, Tamara Pérez, María Julieta González, Daniela Simian, Marcela A. Hermoso, Rodrigo Quera. Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolutionBMC Gastroenterology 2016; 16(1) doi: 10.1186/s12876-016-0520-6
41
Marina García-Miguel, M. Julieta González, Rodrigo Quera, Marcela A. Hermoso. Innate Immunity Modulation by the IL-33/ST2 System in Intestinal MucosaBioMed Research International 2013; 2013: 1 doi: 10.1155/2013/142492
42
Enzo Candia, David Díaz-Jiménez, Patricia Langjahr, Lucía E. Núñez, Marjorie de la Fuente, Nancy Farfán, Francisco López-Kostner, Mario Abedrapo, Manuel Alvarez-Lobos, George Pinedo, Caroll J. Beltrán, Carlos González, María-Julieta González, Rodrigo Quera, Marcela A. Hermoso. Increased production of soluble TLR2 by lamina propria mononuclear cells from ulcerative colitis patientsImmunobiology 2012; 217(6): 634 doi: 10.1016/j.imbio.2011.10.023
43
Seung Min Jung, Jaeseon Lee, Seung Ye Baek, Jae Ho Lee, Jennifer Lee, Kyung-Su Park, Sung-Hwan Park, Ho-Youn Kim, Seung-Ki Kwok. The Interleukin 33/ST2 Axis in Patients with Primary Sjögren Syndrome: Expression in Serum and Salivary Glands, and the Clinical AssociationThe Journal of Rheumatology 2015; 42(2): 264 doi: 10.3899/jrheum.140234
44
Bruce E. Sands. Biomarkers of Inflammation in Inflammatory Bowel DiseaseGastroenterology 2015; 149(5): 1275 doi: 10.1053/j.gastro.2015.07.003
45
Radislav Nakov. New markers in ulcerative colitisClinica Chimica Acta 2019; 497: 141 doi: 10.1016/j.cca.2019.07.033
46
Xinrui Yuan, Krishnapriya Chinnaswamy, Jeanne A. Stuckey, Chao-Yie Yang. Computational Cosolvent Mapping Analysis Leads to Identify Salicylic Acid Analogs as Weak Inhibitors of ST2 and IL33 BindingThe Journal of Physical Chemistry B 2022; 126(12): 2394 doi: 10.1021/acs.jpcb.2c00341
47
Evgenija Homsak, Damien Gruson. Soluble ST2: A complex and diverse role in several diseasesClinica Chimica Acta 2020; 507: 75 doi: 10.1016/j.cca.2020.04.011